CACI International (United Kingdom)

Recent papers from CACI International (United Kingdom)

1. Agricultural Climate Financing for Sub-Saharan Africa post the 2015 Paris Agreement DeclarationJournal of the Knowledge Economy · 2026
2. Strengthening Libya’s primary healthcare workforce: a replicable model for health system resilience in fragile statesBMC Primary Care · 2026
3. Early technology review during prototype development and at proof of concept: the case for developing a sequential versus a single-stage approach to early evidence development for health technologiesInternational Journal of Technology Assessment in Health Care · 2026
4. Yeast identification, antifungal susceptibility testing, and Candida auris screening practices at acute care hospitals and long-term acute care hospitals, United StatesJournal of Clinical Microbiology · 2026
5. Field Triage Errors: A Cross-Sectional Study of Emergency Responders in a Virtual Reality Mass Casualty SimulationDisaster Medicine and Public Health Preparedness · 2025
6. Impact of messaging treatments on stages of change in relational organizing for climate-friendly plant-based dietsPLOS Climate · 2025
7. Alignment in Decision-Making Attributes Predicts Trust and Delegation to AI SystemsJournal of Cognitive Engineering and Decision Making · 2025
8. Perceived self and social relevance of content motivates news sharing across cultures and topics2023
9. Supplemental findings of the 2021 National Blood Collection and Utilization SurveyTransfusion · 2023
10. VR models of death and psychedelics: An un-collapsed high-entropy aesthetic paradigm for design beyond day-to-day phenomenology2023
11. Sepsis Program Activities in Acute Care Hospitals — National Healthcare Safety Network, United States, 2022MMWR Morbidity and Mortality Weekly Report · 2023
12. Transient mid-IR nonlinear refraction in airOptics Express · 2021
13. Estimating the Unit Costs of Healthcare Service Delivery in India: Addressing Information Gaps for Price Setting and Health Technology AssessmentApplied Health Economics and Health Policy · 2020
14. Challenges Associated with Estimating Utility in Wet Age-Related Macular Degeneration: A Novel Regression Analysis to Capture the Bilateral Nature of the DiseaseAdvances in Therapy · 2017
15. Comparison of the Non-VKA Oral Anticoagulants Apixaban, Dabigatran, and Rivaroxaban in the Extended Treatment and Prevention of Venous Thromboembolism: Systematic Review and Network Meta-AnalysisPLoS ONE · 2016
16. Cost-effectiveness of tolvaptan for the treatment of hyponatraemia secondary to syndrome of inappropriate antidiuretic hormone secretion in SwedenBMC Endocrine Disorders · 2016
17. Cost-Effectiveness of Capsaicin 8% Patch Compared with Pregabalin for the Treatment of Patients with Peripheral Neuropathic Pain in ScotlandPLoS ONE · 2016
18. Comparison of the Novel Oral Anticoagulants Apixaban, Dabigatran, Edoxaban, and Rivaroxaban in the Initial and Long-Term Treatment and Prevention of Venous Thromboembolism: Systematic Review and Network Meta-AnalysisPLoS ONE · 2015
19. Allergen immunotherapy for the prevention of allergic disease: protocol for a systematic reviewPediatric Allergy and Immunology · 2015
20. The Budget Impact of Biosimilar Infliximab (Remsima®) for the Treatment of Autoimmune Diseases in Five European CountriesAdvances in Therapy · 2015